Over the last decade, the European medical cannabis landscape has seen a significant surge of new products entering the market, providing patients, especially in the UK and Germany, with a greater variety than ever before.
In 2025, the UK imported more than 30,000 kilograms of cannabis-based medicinal products (CBPMs), more than doubling for the second consecutive year, new data from Prohibition Partners shows.
Since April 2024, Berlin has cemented its place as the spiritual centre of the European cannabis industry.
Germany’s medical cannabis market, which has long been the engine powering Europe’s wider market growth, once again finds itself in a state of flux.
As the sun finally dipped over London on the hottest day of the year, the buzz that had filled the Barbican throughout the first day of Cannabis Europa London 2026 moved a few streets east to 83 Rivington, as the tone shifted from debate to celebration.
Canadian producers shipped 17,067kg of medical cannabis directly to the UK in 2025, more than six times the 2,578kg recorded the year before, according to the latest official Home Office data seen by Business of Cannabis.
This morning, the latest in a now-weekly series of stories in the British mainstream press was published in The Times, for the second week in a row taking aim at the advertising practices of some of the UK’s largest clinics.
The global legal cannabis industry is no longer an emerging market, but a maturing one with established regulatory frameworks, institutional capital, and a growing ecosystem of professional services.
The UK and Germany’s medical cannabis markets both more than doubled in size throughout 2025, once again cementing the countries as the engine behind European market growth.
